Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 202, Issue 4, Pages 541-549Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20041503
Keywords
-
Categories
Funding
- NIAID NIH HHS [R01 AI044259, AI44259] Funding Source: Medline
Ask authors/readers for more resources
The cytokine thymic stromal lymphopoietin (TSLP) has recently been implicated in the pathogenesis of atopic dermatitis (AD) and other allergic diseases in humans. To further characterize its role in this disease process, transgenic mice were generated that express a keratinocyte-specific, tetracycline-inducible TSLP transgene. Skin-specific overexpression of TSLP resulted in an AD-like phenotype, with the development of eczematous lesions containing inflammatory dermal cellular infiltrates, a dramatic increase in Th2 CD4(+) T cells expressing cutaneous homing receptors, and elevated serum levels of IgE. These transgenic mice demonstrate that TSLP can initiate a cascade of allergic inflammation in the skin and provide a valuable animal model for future study of this common disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available